Advertisement

Corrigendum to ‘‘Mechanisms of action of interferon and nucleoside analogues’’ [J Hepatol 39 (2003) S93–S98]

      Declarations of consultancies, funding and relationships that the authors may have with the Pharmaceutical Industry, relating to their work and area of research
      HC Thomas has stated that he has received funding and/or worked as a consultant for Bristol Myers Squibbs, Gilead, and Roche.